Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | MicrobiomeTrials← Back to trialsNCT04804553
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2022-03-17Est. Completion: 2028-03-21
Enrollment target: 60 participants Locations- Landeskrankenhaus Bregenz, Bregenz, Austria
- Universitair Ziekenhuis Gent, Ghent, Belgium
- Centre Hospitalier Regional de la Citadelle, Liège, Belgium
- Ziekenhuis Netwerk Antwerpen Jan Palfijn, Merksem, Belgium
- Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron, France
- Hopital Jeanne de Flandre, Lille, France
- Charite - Universitaetsmedizin Berlin, Campus Virchow, Berlin, Germany
- Universitaetsklinikum Dresden, Dresden, Germany
- An der Schoen Klinik Hamburg Eilbek, Hamburg, Germany
- Asklepios Kinderklinik Sankt Augustin GmbH, Sankt Augustin, Germany
- Agia Sofia Children Hospital, Athens, Greece
- Attikon University General Hospital, Athens, Greece
- General Hospital of Thessaloniki Ippokrateio, Thessaloniki, Greece
- Ospedale Santissima Annunziata, Chieti, Italy
- IRCCS Istituto Giannina Gaslini, Genova, Italy
- Azienda Socio Sanitaria Territoriale Centro Specialistico Ortopedico Traumatologico Gaetano Pini, Milan, Italy
- IRCCS Ospedale Pediatrico Bambino Gesu, Roma, Italy
Other microbiome trials you might be interested in
Rheumatoid Arthritis (RA)Juvenile Idiopathic Arthritis (JIA)Systemic Lupus Erythematosus (SLE)Juvenile Systemic Lupus ErythematosusSystemic Sclerosis (SSc)Idiopathic Inflammatory Myopathies (IIMs)Axial SpondyloarthritisPsoriatic Arthritis (PsA)Granulomatosis With PolyangiitisMicroscopic PolyangiitisAntiphospholipid SyndromeTakayasu Arteritis
The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan…
São Paulo, BrazilEst. completion Dec 30, 2027
Viesoji istaiga Vilniaus universiteto ligonine Santaros klinikos, Vaiku ligonine, Vilnius, LithuaniaUniversitair Medisch Centrum Utrecht, Utrecht, NetherlandsWojewodzki Specjalistyczny Szpital Dzieciecy im sw Ludwika w Krakowie, Krakow, PolandSPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Lodz, PolandNarodowy Instytut Geriatrii Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher, Warsaw, PolandUnidade Local de Saude de Lisboa Ocidental, EPE - Hospital Egas Moniz, Lisbon, PortugalUnidade Local de Saude de Santa Maria, EPE - Hospital de Santa Maria, Lisbon, PortugalUnidade Local de Saude do Alto Minho EPE - Hospital do Conde de Bertiandos, Ponte de Lima, PortugalUnidade Local de Saude de Sao Joao, EPE - Hospital de Sao Joao, Porto, PortugalUnidade Local de Saude de Gaia-Espinho, EPE, Vila Nova de Gaia, PortugalSpitalul Clinic de Urgenta pentru Copii Cluj, Cluj-Napoca, RomaniaSpitalul Clinic de Urgenta pentru Copii Louis Turcanu Timisoara, Timișoara, RomaniaPanorama Medical Centre, Panorama, Western Cape, South AfricaGroote Schuur Hospital, Cape Town, South AfricaHospital Universitario de Canarias, San Cristóbal de La Laguna, Canary Islands, SpainHospital Universitari Vall d Hebron, Barcelona, Catalonia, SpainHospital Sant Joan de Deu, Esplugues de Llobregat, Catalonia, SpainHospital Universitari i Politecnic La Fe, Valencia, Valencia, SpainHospital Universitario Ramon y Cajal, Madrid, SpainHospital Universitario La Paz, Madrid, SpainHacettepe Universitesi Tip Fakultesi Hastanesi, Ankara, Turkey (Türkiye)Istanbul Universitesi Istanbul Tip Fakultesi Hastanesi, Istanbul, Turkey (Türkiye)Istanbul Universitesi Cerrahpasa Tip Fakultesi, Istanbul, Turkey (Türkiye)Umraniye Egitim ve Arastirma Hastanesi, Istanbul, Turkey (Türkiye)Birmingham Childrens Hospital, Birmingham, United KingdomAlder Hey Childrens Hospital, Liverpool, United KingdomNottingham Childrens Hospital, Nottingham, United KingdomJohn Radcliffe Hospital, Oxford, United KingdomModerate to Severe Plaque Psoriasis
The primary purpose of this study is to evaluate the efficacy of bimekizumab administered subcutaneously (sc) compared t…
Fountain Valley, United StatesEst. completion Aug 21, 2028